Consumers pay when drugmakers delay, finds study of over-the-counter drug exclusivity rules

Policies designed to encourage drugmakers to introduce over-the-counter (OTC) versions of previously prescription-only medications may in fact harm consumers, shows a new study co-authored by a University of Massachusetts Amherst economist.

Continue Reading

News Source: medicalxpress.com